Inhaled insulin Afrezza is a great option for a lot of people living with type 1 and type 2 diabetes because it doesn’t involve shots and has a rapid on-rapid off effect. The makers of Afrezza just announced a direct purchase program to help people get it for as little as $4 a day.
read more →
A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →
What happens when you accidentally inject yourself with a big dose of the wrong insulin? Author Sarah Durrand shares how an extreme low blood sugar led her to one of her highest achievements.
read more →
Drs. Jeremy Pettus and Schafer Boeder led our Type 1 Spotlight Series in San Diego recently, and they covered trending topics in type 1 from new oral meds to groundbreaking glucagon spray.
read more →
With several new fast-acting insulins on the market, is it still necessary to pre-bolus before meals? How fast-acting are they really? Endocrinologist and type 1 Dr. Jeremy Pettus compares, contrasts, and gives his vote.
read more →
Many people with type 2 diabetes have fears about starting insulin therapy, but using inhaled insulin, one of the newest insulin options, may get around some of these fears. One thing is for sure, using ANY type of insulin will help control your diabetes and does not represent a failure on your part! Diabetes is a progressive disease, and at least a third of people with type 2 diabetes will eventually need insulin.
read more →
We all have them…mistakes we’ve made that we don’t even want to share with our own mother. Dr. Jeremy Pettus puts it all out there and gets real about what recently happened when he took the right dose of the wrong insulin.
read more →
Did you know CGMs come out of the box with their repeat low alerts set to “off”?
CGM’s are life-changing and life-saving. Learn how to make the most of yours, and use those bells and whistles to your advantage!
Achieving glucose goals is a critical part of overall diabetes management. The better the glucose control the lower the risk of long-term complications . Taking two or more glucose-lowering medications is usually needed in people with type 2 diabetes to achieve normal or near-normal glucose control.
read more →
The pain of insulin injections is well-documented, and the diabetes community is always searching for better alternatives. One such promising technology is the long-awaited OneTouch Via, an insulin patch pump from Johnson & Johnson subsidiary Calibra Medical.
read more →
